Adjuvanted Intranasal Norwalk Virus‐Like Particle Vaccine Elicits Antibodies and Antibody‐Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues
Samer S. El‐Kamary(University of Maryland, Baltimore), Carol O. Tacket(University of Maryland, Baltimore), Marcelo B. Sztein(University of Maryland, Baltimore), Richard Sublett, Robert F. Bargatze(Montana State University), Paul M. Mendelman(Takeda (Switzerland)), Sharon E. Frey(St. Louis VA Medical Center), Jennifer Ferreira(University of Rochester Medicine), Marcela F. Pasetti(University of Maryland Global Campus), David I. Bernstein(Cincinnati Children's Hospital Medical Center), John J. Treanor(University of Maryland, Baltimore), Charles C. Richardson(Harvard University), Wilbur H. Chen(University of Maryland, Baltimore)
Cited by 227
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo.
|Proceedings of the National Academy of Sciences|1991|969
The Underrecognized Burden of Influenza in Young Children
|New England Journal of Medicine|2006|879